Blood Marker Soluble PD-1 Flags Cancer Return After Liver Transplant in Immunotherapy Patients
A pretransplant blood test for soluble PD-1 identified liver cancer patients at high risk of tumor recurrence after immunotherapy and ...
A pretransplant blood test for soluble PD-1 identified liver cancer patients at high risk of tumor recurrence after immunotherapy and ...
A nationwide audit of 64 liver transplant patients with cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma confirms that very small intrahepatic tumours achieve ...
The 30th ILTS Congress in Singapore showcased robotic donor surgery, machine perfusion biomarkers, AI-driven prediction and xenotransplantation milestones, revealing a ...
Living donor liver transplantation (LDLT) has emerged as a promising alternative in the realm of transplant oncology, particularly for patients ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.